Home › Funds › Trails Edge Capital Partners, LP › INBX
Trails Edge Capital Partners, LP position in INBX
INHIBRX BIOSCIENCES INC · Health Care
Trails Edge Capital Partners, LP reported holding 170,000 shares of INBX (INHIBRX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$17.0M, representing 2.44% of its reported portfolio and ranking #19 among its reported holdings. Trails Edge Capital Partners, LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Trails Edge Capital Partners, LP's INBX position evolved
Trails Edge Capital Partners, LP first disclosed a stake in INBX in Q3 2026 at 170,000 shares (US$17.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 170.00K | $17.01M | New |
About INBX and 13F data
INBX (INHIBRX BIOSCIENCES INC) is a Health Care company. 40 other funds we track also report a position in INBX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$123.0M), Sanofi (US$115.9M), Schonfeld Strategic Advisors LLC (US$66.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INBX
- PERCEPTIVE ADVISORS LLC 1.30M sh · $122.96M · Q2 2026
- Sanofi 1.16M sh · $115.89M · Q3 2026
- Schonfeld Strategic Advisors LLC 697.59K sh · $66.10M · Q2 2026
- Sofinnova Investments, Inc. 391.62K sh · $39.19M · Q3 2026
- Parkman Healthcare Partners LLC 360.26K sh · $36.05M · Q3 2026
- PFM Health Sciences, LP 320.33K sh · $32.06M · Q3 2026
- First Turn Management, LLC 171.51K sh · $17.16M · Q3 2026
More on Trails Edge Capital Partners, LP
FAQ
How long has Trails Edge Capital Partners, LP held INBX?
Trails Edge Capital Partners, LP has disclosed INBX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Trails Edge Capital Partners, LP's current position in INBX?
As of Q3 2026, Trails Edge Capital Partners, LP holds 170.00K shares of INBX (INHIBRX BIOSCIENCES INC), valued at $17.01M, representing 2.44% of its reported portfolio and ranking #19.
Has Trails Edge Capital Partners, LP been buying or selling INBX?
In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP newly opened its position in INBX.
Which other funds hold INBX?
Other major institutional holders of INBX include PERCEPTIVE ADVISORS LLC, Sanofi, Schonfeld Strategic Advisors LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.